Parkinson disease: PD biomarkers-use of α-synuclein reaches new levels
- PMID: 21556033
- PMCID: PMC4043344
- DOI: 10.1038/nrneurol.2011.66
Parkinson disease: PD biomarkers-use of α-synuclein reaches new levels
Abstract
Biomarker development is important to the therapeutic imperative for neurodegenerative diseases, as biomarkers hold transformative promise for the design and conduct of clinical trials and, ultimately, for medical management of these diseases. Some of this promise is now being realized in Alzheimer disease, and progress in Parkinson disease is accelerating.
Conflict of interest statement
Competing interests: The author declares no competing interests.
Comment on
-
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X. Lancet Neurol. 2011. PMID: 21317042
Similar articles
-
Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.Eur J Neurosci. 2016 Jan;43(1):3-16. doi: 10.1111/ejn.13056. Epub 2015 Oct 15. Eur J Neurosci. 2016. PMID: 26332448 Free PMC article.
-
Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive review.Mol Biol Rep. 2025 Mar 26;52(1):337. doi: 10.1007/s11033-025-10463-w. Mol Biol Rep. 2025. PMID: 40138119 Review.
-
ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases.Nat Commun. 2024 Nov 11;15(1):9690. doi: 10.1038/s41467-024-53547-0. Nat Commun. 2024. PMID: 39528447 Free PMC article.
-
A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.PLoS One. 2016 Apr 26;11(4):e0153564. doi: 10.1371/journal.pone.0153564. eCollection 2016. PLoS One. 2016. PMID: 27116005 Free PMC article.
-
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update.Biomark Med. 2012 Aug;6(4):419-30. doi: 10.2217/bmm.12.46. Biomark Med. 2012. PMID: 22917144 Review.
Cited by
-
Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening.J Biol Chem. 2012 Sep 28;287(40):33691-705. doi: 10.1074/jbc.M112.379792. Epub 2012 Jul 27. J Biol Chem. 2012. PMID: 22843695 Free PMC article.
References
-
- Mollenhauer B, et al. α-synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol. 2011;10:230–240. - PubMed
-
- Fagan AM, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans. Ann Neurol. 2006;59:512–519. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical